flumazenil has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "NAFLD is the liver manifestation of metabolic syndrome (MS)." | 1.40 | Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study. ( Drazilová, S; Fedacko, J; Gecková, AM; Janicko, M; Jarcuska, P; Kristian, P; Mareková, M; Pella, D; Senajová, G; Siegfried, L; Tkác, M; Veselíny, E, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jarcuska, P | 2 |
| Janicko, M | 1 |
| Drazilová, S | 1 |
| Senajová, G | 1 |
| Veselíny, E | 1 |
| Fedacko, J | 1 |
| Siegfried, L | 1 |
| Kristian, P | 1 |
| Tkác, M | 1 |
| Pella, D | 1 |
| Mareková, M | 1 |
| Gecková, AM | 1 |
1 other study available for flumazenil and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study.
Topics: Adolescent; Adult; C-Reactive Protein; Comorbidity; Cross-Sectional Studies; Diet; Fatty Liver; Fema | 2014 |